What is Kura Oncology's current debt?

Kura Oncology (KURA) reported current debt of $0 in Q4 2025.

How has Kura Oncology's current debt changed year-over-year?

Kura Oncology's current debt decreased by 100.0% year-over-year, from $2.61M to $0.

What is the long-term trend for Kura Oncology's current debt?

Over 2 years (2020 to 2025), Kura Oncology's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $3M to $0.

What does current debt mean?

The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.

Kura Oncology KURA Current Debt

Current Debt at other companies

Johnson & JohnsonJNJ

$17.46B+25.6%

AmgenAMGN

$5.44B+61.4%

Syndax PharmaceuticalsSNDX

$350M+4.2%

AbbVieABBV

$0-100%

Nuvation BioNUVB

$5.79M+1.8%

IncyteINCY

$4.41M-1.5%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.

The official record: Kura Oncology’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's current debt?: Kura Oncology (KURA) reported current debt of $0 in Q4 2025.
How has Kura Oncology's current debt changed year-over-year?: Kura Oncology's current debt decreased by 100.0% year-over-year, from $2.61M to $0.
What is the long-term trend for Kura Oncology's current debt?: Over 2 years (2020 to 2025), Kura Oncology's current debt has grown at a -100.0% compound annual growth rate (CAGR), from $3M to $0.
What does current debt mean?: The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.